Live news related to DBV TECHNOLOGIES stock (FR0010417345): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
DBV Technologies' stock falls by 2.01% to €3.41 in early afternoon trading, within a nearly stable SBF 120 (-0.13%). The French biotech ranks 118th in…
French biotech company advances 2.85% to €3.54 in mid-morning trading, alongside a 1.58% increase in the CAC 40. The stock is trading close to its 50-…
The stock of the French biotech company increased by 2.2% to €3.43 mid-session in a rising Parisian market. The previous day, Kempen maintained its bu…
The stock of the French biotech company declined sharply during the session to €3.36, following the announcement of its first quarter 2026 results las…
DBV Technologies unveils its regulatory submission schedule for its flagship pediatric allergy treatment. The French biotech plans two biologics licen…
DBV Technologies reports a cash position of $229 million as of March 31, 2026, funded by the full exercise of warrants from the private placement in M…
DBV Technologies is up nearly 2% this Tuesday, April 28 at mid-session, trading at 3.582 euros after closing at 3.512 euros the previous day. The biot…
DBV Technologies shows a notable rebound this Monday, April 27, in a slightly positive Parisian market. The stock of the biotech specializing in food …
DBV Technologies shows a notable increase this Monday, bringing its share price to €3.75 during the session. The biotech company specializing in food …
DBV Technologies fell by 3.43% this Wednesday, trading at 3.72 euros, in a pullback that contrasts with the recent bullish trend. The biotech company,…
